Clinical Trial Update: Engineered Immune Effectors Against Cervical Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for engineered immune effectors targeting cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Cervical Cancer | Phase 1, Phase 2 | Status: UNKNOWN